Alpha 2.0
Login Register
» Authors » Rosemary C Murphy

Rosemary C Murphy

Explore the profile of Rosemary C Murphy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 197
Followers 0
Related Specialties
Gastroenterology
Microbiology
Health Services
Top 10 Co-Authors
M Michele Manos
Beth P Bell
Norah A Terrault
Andre N Sofair
Atif Zaman
Valentina A Shvachko
Ann Thomas
Stephanie R Bialek
Nicole Stabach
Kathy B Dhotre
Published In
J Clin Gastroenterol
Hepatology
J Med Virol
Am J Gastroenterol
Patient
Affiliations
Soon will be listed here.
Recent Articles
1.
Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting
Price J, Murphy R, Shvachko V, Pauly M, Manos M
Dig Dis Sci . 2014 Aug; 59(12):3043-52. PMID: 25102983
Background: In 2011, the FDA approved telaprevir (TVR) and boceprevir (BOC) for use with pegylated interferon and ribavirin to treat hepatitis C virus (HCV) genotype 1. We aimed to evaluate...
2.
Physical, social, and psychological consequences of treatment for hepatitis C : a community-based evaluation of patient-reported outcomes
Manos M, Ho C, Murphy R, Shvachko V
Patient . 2013 Feb; 6(1):23-34. PMID: 23420134
Background: Hepatitis C virus (HCV) antiviral therapy entails a long treatment course, as well as significant side effects that can lead to medication non-adherence and premature termination of treatment. Few...
3.
Distribution of hepatitis C virus genotypes in a diverse US integrated health care population
Manos M, Shvachko V, Murphy R, Arduino J, Shire N
J Med Virol . 2012 Sep; 84(11):1744-50. PMID: 22997077
Hepatitis C virus (HCV) genotypes influence response to therapy, and recently approved direct-acting antivirals are genotype-specific. Genotype distribution information can help to guide antiviral development and elucidate infection patterns. HCV...
4.
Complementary and alternative medicine use in chronic liver disease patients
Ferrucci L, Bell B, Dhotre K, Manos M, Terrault N, Zaman A, et al.
J Clin Gastroenterol . 2009 Sep; 44(2):e40-5. PMID: 19779363
Goals: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus...
5.
The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance
Sofair A, Barry V, Manos M, Thomas A, Zaman A, Terrault N, et al.
J Clin Gastroenterol . 2009 Sep; 44(4):301-7. PMID: 19745759
Goals: We describe the epidemiology of outpatients newly diagnosed with chronic alcoholic liver disease and describe predictors of cirrhosis and referral for specialty care. Background: Alcohol is a major cause...
6.
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance
Bell B, Manos M, Zaman A, Terrault N, Thomas A, Navarro V, et al.
Am J Gastroenterol . 2008 Aug; 103(11):2727-36. PMID: 18684170
Objectives: Chronic liver disease (CLD) is an important cause of morbidity and mortality, but the epidemiology is not well described. We conducted prospective population-based surveillance to estimate newly diagnosed CLD...
7.
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment
Manos M, Leyden W, Murphy R, Terrault N, Bell B
Hepatology . 2008 Feb; 47(4):1150-7. PMID: 18264998
Unlabelled: Standard death certificate-based methods for ascertaining deaths due to chronic liver disease (CLD), such as the U.S. vital statistics approach, rely on a limited set of diagnostic codes to...